首页 > 最新文献

Nephrologie & therapeutique最新文献

英文 中文
Argument for the annual monitoring of specialized biological examinations carried out in hemodialysis 对血液透析中进行的专门生物检查进行年度监测的论据
Pub Date : 2024-05-15 DOI: 10.1684/ndt.2024.75
Antoine Braconnier, Lucile Mercadal, Jean-Michel Poux
{"title":"Argument for the annual monitoring of specialized biological examinations carried out in hemodialysis","authors":"Antoine Braconnier, Lucile Mercadal, Jean-Michel Poux","doi":"10.1684/ndt.2024.75","DOIUrl":"https://doi.org/10.1684/ndt.2024.75","url":null,"abstract":"","PeriodicalId":94153,"journal":{"name":"Nephrologie & therapeutique","volume":"20 2","pages":"147-154"},"PeriodicalIF":0.0,"publicationDate":"2024-05-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140924122","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Argument justifying the measurement of routine biochemical markers in hemodialysis 血液透析中常规生化指标测量的合理性论证
Pub Date : 2024-05-15 Epub Date: 2024-04-04 DOI: 10.1684/ndt.2024.74
Céline Nodimar, Philippe Chauveau
{"title":"Argument justifying the measurement of routine biochemical markers in hemodialysis","authors":"Céline Nodimar, Philippe Chauveau","doi":"10.1684/ndt.2024.74","DOIUrl":"10.1684/ndt.2024.74","url":null,"abstract":"","PeriodicalId":94153,"journal":{"name":"Nephrologie & therapeutique","volume":"20 2","pages":"143-146"},"PeriodicalIF":0.0,"publicationDate":"2024-05-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140924132","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Second wave of the repository of biological examinations in hemodialysis 关于血液透析患者生物监测的论证--SFNDT 透析委员会为提高透析质量而起草的第二批建议。
Pub Date : 2024-05-15 DOI: 10.1684/ndt.2024.76
Thierry Lobbedez, Jean-Michel Poux
{"title":"Second wave of the repository of biological examinations in hemodialysis","authors":"Thierry Lobbedez, Jean-Michel Poux","doi":"10.1684/ndt.2024.76","DOIUrl":"10.1684/ndt.2024.76","url":null,"abstract":"","PeriodicalId":94153,"journal":{"name":"Nephrologie & therapeutique","volume":"20 2","pages":"141-142"},"PeriodicalIF":0.0,"publicationDate":"2024-05-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140916517","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Arguments for the screening of essential viral markers in the context of chronic hemodialysis patient surveillance 在慢性血液透析患者监测中筛查基本病毒标记物的论据
Pub Date : 2024-05-15 DOI: 10.1684/ndt.2024.73
Vincent Thibault
{"title":"Arguments for the screening of essential viral markers in the context of chronic hemodialysis patient surveillance","authors":"Vincent Thibault","doi":"10.1684/ndt.2024.73","DOIUrl":"https://doi.org/10.1684/ndt.2024.73","url":null,"abstract":"","PeriodicalId":94153,"journal":{"name":"Nephrologie & therapeutique","volume":"20 2","pages":"156-159"},"PeriodicalIF":0.0,"publicationDate":"2024-05-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140924142","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Fibromuscular dysplasia of the renal arteries: what do we know in 2024? 肾动脉纤维肌性发育不良:2024 年我们知道些什么?
Pub Date : 2024-05-15 DOI: 10.1684/ndt.2024.70
Corentin Tournebize, Sandrine Lemoine, Caroline Pelletier

Fibromuscular dysplasia (FMD) is a rare nonatherosclerotic, noninflammatory vascular disease affecting mostly renal and carotid arteries and is the second most frequent cause of renal artery stenosis. The symptomatology is dominated by arterial hypertension due to the frequent involvement of the renal arteries and depends on the location of the lesions. Most of the cases are middle-aged women of Caucasian origin. There are two subtypes based on angiographic aspect: multifocal FMD (80% of the cases) and focal FMD (rarer with a more balanced sex ratio). Angioplasty of the renal arteries is generally disappointing with less than 50% cure of hypertension. It appears necessary to improve our knowledge of the FMD and to optimize the selection of eligible patients for revascularization with transdisciplinary collegial therapeutic decision.

纤维肌性发育不良(FMD)是一种罕见的非动脉粥样硬化性、非炎症性血管疾病,主要累及肾动脉和颈动脉,是导致肾动脉狭窄的第二大原因。由于肾动脉经常受累,症状以动脉高血压为主,并取决于病变的位置。大多数病例为高加索血统的中年女性。根据血管造影可分为两种亚型:多灶性 FMD(占 80% 的病例)和局灶性 FMD(较少见,性别比例更均衡)。肾动脉血管成形术通常效果不佳,高血压治愈率不到 50%。看来,我们有必要提高对 FMD 的认识,并通过跨学科联合治疗决策,优化对符合血管重建条件的患者的选择。
{"title":"Fibromuscular dysplasia of the renal arteries: what do we know in 2024?","authors":"Corentin Tournebize, Sandrine Lemoine, Caroline Pelletier","doi":"10.1684/ndt.2024.70","DOIUrl":"https://doi.org/10.1684/ndt.2024.70","url":null,"abstract":"<p><p>Fibromuscular dysplasia (FMD) is a rare nonatherosclerotic, noninflammatory vascular disease affecting mostly renal and carotid arteries and is the second most frequent cause of renal artery stenosis. The symptomatology is dominated by arterial hypertension due to the frequent involvement of the renal arteries and depends on the location of the lesions. Most of the cases are middle-aged women of Caucasian origin. There are two subtypes based on angiographic aspect: multifocal FMD (80% of the cases) and focal FMD (rarer with a more balanced sex ratio). Angioplasty of the renal arteries is generally disappointing with less than 50% cure of hypertension. It appears necessary to improve our knowledge of the FMD and to optimize the selection of eligible patients for revascularization with transdisciplinary collegial therapeutic decision.</p>","PeriodicalId":94153,"journal":{"name":"Nephrologie & therapeutique","volume":"20 2","pages":"131-139"},"PeriodicalIF":0.0,"publicationDate":"2024-05-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140924146","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Factors associated with therapeutic non-adherence in renal transplant patients: a bicentric study in Algeria 肾移植患者不坚持治疗的相关因素:阿尔及利亚的一项双中心研究。
Pub Date : 2024-05-15 DOI: 10.1684/ndt.2024.69
Akli Islem Chebli, Zeyneb Chelighem, Emad Shalabi, Younes Zebbiche, Nada Boubidi, Bahi Baraa, Nechoia Boumalha, Djihad Bouhlassa, Sara Abdennour

Introduction: Medication non-adherence is a global concern, particularly in the context of renal transplantation, where it leads to graft failures, increased hospitalizations, diminished quality of life for patients, and higher healthcare costs. The aim of this study was to assess the level of therapeutic adherence among Algerian kidney transplant recipients and identify potential influencing factors.

Methods: A descriptive, cross-sectional bicenter study was conducted among kidney transplant patients receiving outpatient care at two specialized medical centers in Algeria: the Urology Department of the Hospital Establishment for Urology, Nephrology, and Renal Transplantation in Constantine, and the Nephrology and Renal Transplantation Department of the University Hospital Center (CHU) in Blida, spanning from January to December 2022. Therapeutic adherence was assessed using the 8-item Morisky questionnaire, while the level of knowledge was analyzed through a 12-item questionnaire. Logistic regression was used to identify factors associated with non-adherence to therapy.

Results: This study included 130 patients with an average age of 47 years and a sex ratio of 1.7. The results revealed therapeutic non-adherence in 40.8% of the patients. Multivariate analysis identified several potentially associated factors, including residence, unemployment status, lack of affiliation with a health insurance fund, the use of a therapeutic regimen involving triple therapy, the occurrence of adverse effects, limited education level, and insufficient disease knowledge. Furthermore, non-adherence was associated with an increased risk of graft rejection.

Conclusion: The findings of this study highlight concerning therapeutic adherence among kidney transplant recipients, emphasizing the crucial importance of therapeutic education to improve treatment adherence and underscoring the need to integrate these factors into clinical patient management.

导言:不遵医嘱用药是一个全球关注的问题,尤其是在肾移植领域,它会导致移植失败、住院次数增加、患者生活质量下降以及医疗费用增加。本研究旨在评估阿尔及利亚肾移植受者的治疗依从性水平,并找出潜在的影响因素:这项描述性横断面双中心研究的对象是在阿尔及利亚两家专科医疗中心接受门诊治疗的肾移植患者,这两家医疗中心分别是君士坦丁市泌尿学、肾脏病学和肾移植医院的泌尿科和布利达市大学医院中心(CHU)的肾脏病学和肾移植科,研究时间跨度为 2022 年 1 月至 12 月。治疗依从性通过 8 项莫里斯基问卷进行评估,知识水平则通过 12 项问卷进行分析。采用逻辑回归法确定与不坚持治疗相关的因素:本研究共纳入 130 名患者,平均年龄 47 岁,男女比例为 1.7。结果显示,40.8%的患者不坚持治疗。多变量分析发现了几个潜在的相关因素,包括居住地、失业状况、未加入医疗保险基金、使用涉及三联疗法的治疗方案、出现不良反应、教育水平有限以及疾病知识不足。此外,不坚持治疗与移植排斥风险增加有关:本研究结果强调了肾移植受者治疗依从性的问题,强调了治疗教育对提高治疗依从性的重要性,并强调了将这些因素纳入临床患者管理的必要性。
{"title":"Factors associated with therapeutic non-adherence in renal transplant patients: a bicentric study in Algeria","authors":"Akli Islem Chebli, Zeyneb Chelighem, Emad Shalabi, Younes Zebbiche, Nada Boubidi, Bahi Baraa, Nechoia Boumalha, Djihad Bouhlassa, Sara Abdennour","doi":"10.1684/ndt.2024.69","DOIUrl":"10.1684/ndt.2024.69","url":null,"abstract":"<p><strong>Introduction: </strong>Medication non-adherence is a global concern, particularly in the context of renal transplantation, where it leads to graft failures, increased hospitalizations, diminished quality of life for patients, and higher healthcare costs. The aim of this study was to assess the level of therapeutic adherence among Algerian kidney transplant recipients and identify potential influencing factors.</p><p><strong>Methods: </strong>A descriptive, cross-sectional bicenter study was conducted among kidney transplant patients receiving outpatient care at two specialized medical centers in Algeria: the Urology Department of the Hospital Establishment for Urology, Nephrology, and Renal Transplantation in Constantine, and the Nephrology and Renal Transplantation Department of the University Hospital Center (CHU) in Blida, spanning from January to December 2022. Therapeutic adherence was assessed using the 8-item Morisky questionnaire, while the level of knowledge was analyzed through a 12-item questionnaire. Logistic regression was used to identify factors associated with non-adherence to therapy.</p><p><strong>Results: </strong>This study included 130 patients with an average age of 47 years and a sex ratio of 1.7. The results revealed therapeutic non-adherence in 40.8% of the patients. Multivariate analysis identified several potentially associated factors, including residence, unemployment status, lack of affiliation with a health insurance fund, the use of a therapeutic regimen involving triple therapy, the occurrence of adverse effects, limited education level, and insufficient disease knowledge. Furthermore, non-adherence was associated with an increased risk of graft rejection.</p><p><strong>Conclusion: </strong>The findings of this study highlight concerning therapeutic adherence among kidney transplant recipients, emphasizing the crucial importance of therapeutic education to improve treatment adherence and underscoring the need to integrate these factors into clinical patient management.</p>","PeriodicalId":94153,"journal":{"name":"Nephrologie & therapeutique","volume":"20 2","pages":"95-111"},"PeriodicalIF":0.0,"publicationDate":"2024-05-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140916527","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Highlights of the SFNDT congress - October 3 to 6 2023, Liège 2023 年 10 月 3-6 日,列日,SFNDT 大会亮点
Pub Date : 2024-04-11 DOI: 10.1684/ndt.2024.61
Stéphane Burtey
{"title":"Highlights of the SFNDT congress - October 3 to 6 2023, Liège","authors":"Stéphane Burtey","doi":"10.1684/ndt.2024.61","DOIUrl":"10.1684/ndt.2024.61","url":null,"abstract":"","PeriodicalId":94153,"journal":{"name":"Nephrologie & therapeutique","volume":"20 S1","pages":"3-4"},"PeriodicalIF":0.0,"publicationDate":"2024-04-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140864207","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The highlights of dialysis in 2023 2023 年透析的亮点
Pub Date : 2024-04-11 DOI: 10.1684/ndt.2024.66
Stanislas Bataille, Céline Nodimar

There has been a wealth of new developments in dialysis this year with the publication of several trials relating to dialysis technique, physical activity and the use of new dialysis treatments. Quality of life should be assessed and managed in all dialysis patients.Lowering the temperature of the dialysis bath in the MyTemp trial does not appear to have an effect on mortality and cardiovascular events. High volume convective hemodiafiltration currently represents the reference technique in hemodialysis; the Convince study confirms its superiority in terms of all-cause mortality.The DIATT study shows the benefit of the presence of an adapted physical activity professional to promote physical activity in dialysis patients and shows that it is necessary for this support to be reimbursed.The RENAL-AF and AXADIA-AFNET 8 studies lack power to conclude on the use of new oral anticoagulants in hemodialysis. For angiotensin receptor neprilysin inhibitors, studies are too weak to allow their use. SGLT2 inhibitors could be used in peritoneal dialysis to increase diuresis or delay the appearance of peritoneal fibrosis but to date only studies on models animals exist. Factor XI inhibitors are a new therapeutic class that could be used and would reduce the risk of thrombosis and hemorrhage.Increasingly, the feelings of patients and caregivers are more and more taken into account. Patient/caregiver communication must be at the heart of care. We will also be looking at the conservative treatment, the management of pruritus in hemodialysis and finally the care of patients with calciphylaxis.

今年,透析领域取得了大量新进展,公布了几项与透析技术、体育锻炼和使用新型透析疗法有关的试验。在 MyTemp 试验中,降低透析槽的温度似乎对死亡率和心血管事件没有影响。高容量对流血液透析滤过目前是血液透析的参考技术;Convince 研究证实了该技术在降低全因死亡率方面的优越性。DIATT 研究表明,有专业体育活动人员在透析患者中推广体育活动有益无害,并表明有必要对这种支持进行报销。RENAL-AF 和 AXADIA-AFNET 8 研究缺乏对血液透析中使用新型口服抗凝剂的结论。至于血管紧张素受体肾酶抑制剂,由于研究结果过于薄弱,因此无法使用。SGLT2 抑制剂可用于腹膜透析,以增加利尿或延缓腹膜纤维化的出现,但迄今为止只有对模型动物的研究。因子 XI 抑制剂是一种可用于降低血栓形成和出血风险的新型治疗药物。患者/护理人员的沟通必须成为护理工作的核心。我们还将探讨保守疗法、血液透析中瘙痒症的处理以及钙襄病患者的护理。
{"title":"The highlights of dialysis in 2023","authors":"Stanislas Bataille, Céline Nodimar","doi":"10.1684/ndt.2024.66","DOIUrl":"10.1684/ndt.2024.66","url":null,"abstract":"<p><p>There has been a wealth of new developments in dialysis this year with the publication of several trials relating to dialysis technique, physical activity and the use of new dialysis treatments. Quality of life should be assessed and managed in all dialysis patients.\u0000Lowering the temperature of the dialysis bath in the MyTemp trial does not appear to have an effect on mortality and cardiovascular events. High volume convective hemodiafiltration currently represents the reference technique in hemodialysis; the Convince study confirms its superiority in terms of all-cause mortality.\u0000The DIATT study shows the benefit of the presence of an adapted physical activity professional to promote physical activity in dialysis patients and shows that it is necessary for this support to be reimbursed.\u0000The RENAL-AF and AXADIA-AFNET 8 studies lack power to conclude on the use of new oral anticoagulants in hemodialysis. For angiotensin receptor neprilysin inhibitors, studies are too weak to allow their use. SGLT2 inhibitors could be used in peritoneal dialysis to increase diuresis or delay the appearance of peritoneal fibrosis but to date only studies on models animals exist. Factor XI inhibitors are a new therapeutic class that could be used and would reduce the risk of thrombosis and hemorrhage.\u0000Increasingly, the feelings of patients and caregivers are more and more taken into account. Patient/caregiver communication must be at the heart of care. We will also be looking at the conservative treatment, the management of pruritus in hemodialysis and finally the care of patients with calciphylaxis.</p>","PeriodicalId":94153,"journal":{"name":"Nephrologie & therapeutique","volume":"20 S1","pages":"5-15"},"PeriodicalIF":0.0,"publicationDate":"2024-04-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140874045","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Why is health literacy an essential component of health of individuals with chronic kidney disease 为什么说健康知识是慢性肾病患者健康的重要组成部分?
Pub Date : 2024-04-04 DOI: 10.1684/ndt.2024.71
Lucile Paris, Thierry Lobbedez, Valérie Châtelet

Health literacy (HL) is the ability of individuals to access, understand and use health information to improve their health. It is a multidimensional and contextual concept, whose definition has been enriched over time. Considered both as a health risk factor and a skill to be developed by individuals, HL also depends on the healthcare system in which patients have to navigate, and on healthcare professionals’ awareness of this concept. In order to promote shared decision-making and thus individual empowerment in the healthcare, HL should be at the core of the concerns of nephrology care teams.

健康素养(HL)是指个人获取、理解和使用健康信息以改善自身健康的能力。它是一个多层面的概念,随着时间的推移,其定义也在不断丰富。健康知识既被视为一种健康风险因素,也是个人需要培养的一种技能,它还取决于患者所处的医疗保健系统,以及医疗保健专业人员对这一概念的认识。为了促进共同决策,从而增强个人在医疗保健中的能力,HL 应成为肾脏病护理团队关注的核心问题。
{"title":"Why is health literacy an essential component of health of individuals with chronic kidney disease","authors":"Lucile Paris, Thierry Lobbedez, Valérie Châtelet","doi":"10.1684/ndt.2024.71","DOIUrl":"https://doi.org/10.1684/ndt.2024.71","url":null,"abstract":"<p><p>Health literacy (HL) is the ability of individuals to access, understand and use health information to improve their health. It is a multidimensional and contextual concept, whose definition has been enriched over time. Considered both as a health risk factor and a skill to be developed by individuals, HL also depends on the healthcare system in which patients have to navigate, and on healthcare professionals’ awareness of this concept. In order to promote shared decision-making and thus individual empowerment in the healthcare, HL should be at the core of the concerns of nephrology care teams.</p>","PeriodicalId":94153,"journal":{"name":"Nephrologie & therapeutique","volume":"20 2","pages":"1-8"},"PeriodicalIF":0.0,"publicationDate":"2024-04-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140924152","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Évaluation pharmaco-économique de la transplantation rénale à l’établissement hospitalier et universitaire d’Oran : analyse des coûts et implications 奥兰大学医院肾移植的药物经济学评估:成本分析及影响
Pub Date : 2024-04-01 DOI: 10.1684/ndt.2024.72
Mohamed Sadeg Amine Amarni, H. Fetati, Kada Djoudad, B. Bendifallah, F. Zerdoumi, H. Toumi
IntroductionIn Algeria, the number of patients treated by dialysis is estimated at 23,798 in 2019. Kidney transplantation is the best therapeutic option for patients suffering from end stage kidney Disease (ESKD). However, this procedure is costly and requires complex management. The aim of this study is to assess the costs associated with kidney transplantation at the University Hospital Establishment of Oran, Algeria (UHEO).Materials and methodsA retrospective, descriptive, monocentric study was carried out on 31 patients who underwent kidney transplantation at the UHEO. Estimated costs included drugs, consumables, imaging and laboratory tests for pre-transplant examinations, immediate post-transplant hospitalization, post-transplant follow-up and management of any complications.ResultsThe average cost of graft preparation was 485,438.31 Algerian Dinar (DZD). Immediate post-transplant hospitalization represented an average cost of 375,484.70 DZD. The first year post-transplantation was the most costly with an average cost of 1,305,197.40 DZD mainly attributed to treatment, hospitalization, clinical and paraclinical examinations.ConclusionThis study estimated the cost of kidney transplantation at the UHEO and revealed that the cost of the first year is the most important due to many factors. It also showed that costs tend to decrease with the age of the transplant and the clinical stability of the recipient.
导言2019 年,阿尔及利亚接受透析治疗的患者人数预计为 23798 人。肾移植是终末期肾病(ESKD)患者的最佳治疗选择。然而,这种手术费用昂贵,而且需要复杂的管理。本研究旨在评估阿尔及利亚奥兰大学医院(UHEO)肾移植手术的相关费用。材料和方法对在奥兰大学医院接受肾移植手术的 31 名患者进行了回顾性、描述性、单中心研究。估算的费用包括移植前检查、移植后立即住院、移植后随访和并发症处理所需的药物、耗材、成像和实验室检测费用。结果移植准备的平均费用为 485 438.31 阿尔及利亚第纳尔(DZD)。移植后立即住院的平均费用为 375 484.70 第纳尔。移植后第一年的费用最高,平均费用为 1,305,197.40 第纳尔,主要用于治疗、住院、临床和辅助检查。研究还显示,随着移植年龄的增长和受者临床病情的稳定,费用呈下降趋势。
{"title":"Évaluation pharmaco-économique de la transplantation rénale à l’établissement hospitalier et universitaire d’Oran : analyse des coûts et implications","authors":"Mohamed Sadeg Amine Amarni, H. Fetati, Kada Djoudad, B. Bendifallah, F. Zerdoumi, H. Toumi","doi":"10.1684/ndt.2024.72","DOIUrl":"https://doi.org/10.1684/ndt.2024.72","url":null,"abstract":"Introduction\u0000In Algeria, the number of patients treated by dialysis is estimated at 23,798 in 2019. Kidney transplantation is the best therapeutic option for patients suffering from end stage kidney Disease (ESKD). However, this procedure is costly and requires complex management. The aim of this study is to assess the costs associated with kidney transplantation at the University Hospital Establishment of Oran, Algeria (UHEO).\u0000\u0000\u0000Materials and methods\u0000A retrospective, descriptive, monocentric study was carried out on 31 patients who underwent kidney transplantation at the UHEO. Estimated costs included drugs, consumables, imaging and laboratory tests for pre-transplant examinations, immediate post-transplant hospitalization, post-transplant follow-up and management of any complications.\u0000\u0000\u0000Results\u0000The average cost of graft preparation was 485,438.31 Algerian Dinar (DZD). Immediate post-transplant hospitalization represented an average cost of 375,484.70 DZD. The first year post-transplantation was the most costly with an average cost of 1,305,197.40 DZD mainly attributed to treatment, hospitalization, clinical and paraclinical examinations.\u0000\u0000\u0000Conclusion\u0000This study estimated the cost of kidney transplantation at the UHEO and revealed that the cost of the first year is the most important due to many factors. It also showed that costs tend to decrease with the age of the transplant and the clinical stability of the recipient.","PeriodicalId":94153,"journal":{"name":"Nephrologie & therapeutique","volume":"430 ","pages":"1-10"},"PeriodicalIF":0.0,"publicationDate":"2024-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140786074","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Nephrologie & therapeutique
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1